Categories : Endocrine & Metabolic
Product Packaging : 10 / 30 tablets
Product Composition : 1 mg / 500 mg
Send MessageGlimepiride & Metformin Prolonged-Release Tablets are a well-balanced antidiabetic combination developed to provide sustained and effective glycemic control in patients with type 2 diabetes mellitus. This formulation combines Glimepiride, a potent sulfonylurea that enhances insulin secretion from pancreatic beta cells, with Metformin in a prolonged-release form that reduces hepatic glucose production and improves insulin sensitivity.
The prolonged-release technology is designed to ensure gradual and consistent drug delivery over an extended duration, helping maintain stable blood glucose levels while minimizing fluctuations. This dual combination is widely prescribed for patients who require enhanced glycemic control beyond monotherapy, offering both efficacy and convenience in long-term diabetes care.
Genliva Wellness LLP, Himatnagar, India, is a trusted glimepiride metformin prolonged release tablet manufacturer India, delivering high-quality formulations suitable for global pharmaceutical distribution and contract manufacturing requirements.
Glimepiride & Metformin Prolonged-Release Tablets are combination antidiabetic medications designed to provide effective and sustained blood glucose control in type 2 diabetes mellitus. The prolonged-release formulation supports gradual drug release for better glycemic management.
These tablets are commonly used for the treatment of type 2 diabetes mellitus along with diet and exercise. They help improve glycemic control and support long-term metabolic management.
Glimepiride & Metformin Prolonged-Release Tablets provide dual-action glucose control with prolonged therapeutic support and improved patient convenience for effective diabetes management.
